ARDENA Trademark Information

Trademark by Pharmavize nv

Pharmaceutical research and pharmaceutical development; inspection of pharmaceutical products; research on pharmaceutical products; testing of pharmaceutical products; scientific investigations of pharmaceutical products for medical purposes; pharmaceutical development of drugs; development of pharmaceutical products; medical and pharmaceutical research services; consultancy pertaining to pharmacology; qualitative evaluation of pharmaceuticals...

Legal consultation and advice; reviewing standards and practices to assure compliance with pharmaceutical laws and regulations

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (045)
Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: ARDENA
Status/Status Date:
REGISTERED
12/19/2017
Estimated Renewal Deadline: December 19, 2023
Serial Number: 79213596
Filing Date: 3/8/2017
Registration Number: 5357360
Registration Date: 12/19/2017
Goods and Services: Pharmaceutical research and pharmaceutical development; inspection of pharmaceutical products; research on pharmaceutical products; testing of pharmaceutical products; scientific investigations of pharmaceutical products for medical purposes; pharmaceutical development of drugs; development of pharmaceutical products; medical and pharmaceutical research services; consultancy pertaining to pharmacology; qualitative evaluation of pharmaceuticals; research relating to pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research regarding pharmaceutical products; research in the field of pharmacogenetics; scientific research in the field of pharmaceutics; testing of the effectiveness of pharmaceutical products; research and development services in the field of biology, gynecology, biotechnology, for others in the pharmaceutical industry; conducting clinical trials for others in the field of pharmaceutical products; research and development in the pharmaceutical field and biotechnology; consultancy relating to research and development in the pharmaceutical field; providing scientific research information in the field of clinical trials of pharmaceuticals; conducting early evaluations in the field of new pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research; providing scientific advice in relation to carbon offsetting; scientific testing; research and development services; conducting scientific feasibility studies; scientific analysis, namely, chemical analysis; scientific and technological services, namely, design in the field of computer networking hardware, computer datacenter architecture, scientific and technological services, namely, scientific research, analysis, testing, in the field of pharmaceuticals; providing scientific information in the field of biology, gynecology, biotechnology; providing of scientific research information in the field of, physics, genetics, pharmaceutical, biotechnology, gynecology; scientific medical research; scientific research for medical purposes; research in the field of physics, bacteriology, gynecology, biotechnology; contract research related to molecular sciences; research relating to molecular sciences; scientific research related to chemistry and biology; providing scientific research information in the field of genetics, physics, pharmaceuticals, biotechnology, organic chemistry
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 10/3/2017
Last Applicant/Owner:
Pharmavize nv
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
REGISTERED
12/19/2017
Correspondent Search:
Martin W. Schiffmiller is a correspondent of ARDENA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on